MEDI 281-Substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics

MEDI 281-Substrate-mimetic inhibitors of Akt as potential anti-cancer therapeutics

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Kayser, K, Glenn, M, Yang, L, Cheng, J, Hamilton, A
Formáid:	Journal article
Foilsithe / Cruthaithe:	2006

Míreanna comhchosúla

Non-peptidic substrate-mimetic inhibitors of Akt as potential anti-cancer agents.
de réir: Kayser-Bricker, K, et al.
Foilsithe / Cruthaithe: (2009)

MEDI 277-Novel alpha-helix mimetics with increased water solubility
de réir: Cummings, C, et al.
Foilsithe / Cruthaithe: (2008)

MEDI 16-Inhibitors of the FBP-FUSE interaction as potential anticancer agents
de réir: Wyrembak, P, et al.
Foilsithe / Cruthaithe: (2007)

MEDI 77-Small alpha-helix mimetics for the inhibition of the estrogen receptor-coactivator interaction
de réir: Becerril, J, et al.
Foilsithe / Cruthaithe: (2006)

Heparin Mimetics: Their Therapeutic Potential
de réir: Shifaza Mohamed, et al.
Foilsithe / Cruthaithe: (2017-10-01)

alpha-Helix mimetics as inhibitors of protein-protein interactions.
de réir: Saraogi, I, et al.
Foilsithe / Cruthaithe: (2008)

Editorial 28.1
de réir: Rodrigo Moreno Marques, et al.
Foilsithe / Cruthaithe: (2019-04-01)

Applications: Abstracts 281-336
de réir: Swiss Chemical Society
Foilsithe / Cruthaithe: (2005-07-01)

ZNF281/Zfp281 is a target of miR-1 and counteracts muscle differentiation
de réir: Nicolai, S, et al.
Foilsithe / Cruthaithe: (2019)

ZNF281/Zfp281 is a target of miR‐1 and counteracts muscle differentiation
de réir: Sara Nicolai, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Sugar mimetics: Multicomponent glycosyltransferase inhibitors
de réir: Lucas, R, et al.
Foilsithe / Cruthaithe: (2005)

The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer’s Disease
de réir: Dustin Chernick, et al.
Foilsithe / Cruthaithe: (2020-09-01)

Future Therapeutic Directions for Smac-Mimetics
de réir: Emma Morrish, et al.
Foilsithe / Cruthaithe: (2020-02-01)

MEDI 298-Design, synthesis and evaluation of inhibitors for the IL-2/IL-2R alpha interaction
de réir: Saraogi, I, et al.
Foilsithe / Cruthaithe: (2008)

COMPARISON BETWEEN ISO 281:1990 AND ISO 281:2007 CALCULATION METHOD FOR ROLLING BEARING LIFE
de réir: JIANG YuXiao, et al.
Foilsithe / Cruthaithe: (2015-01-01)

Identification of natural phytochemicals as AKT2 inhibitors using molecular docking and dynamics simulations as potential cancer therapeutics
de réir: Jibon Kumar Paul, et al.
Foilsithe / Cruthaithe: (2025-01-01)

ZAT 281/4 - Pengantar Mikropemproses
de réir: PPSF, Pusat Pengajian Sains Fizik
Foilsithe / Cruthaithe: (2003)

Pré-textuais / Sumário 28.1
de réir: Yara Elizabeth Alves
Foilsithe / Cruthaithe: (2019-04-01)

Contribuíram nesta edição (28.1)
Foilsithe / Cruthaithe: (2020-02-01)

Contribuíram nesta edição (28.1)
Foilsithe / Cruthaithe: (2020-02-01)

SMAC Mimetics as Therapeutic Agents in HIV Infection
de réir: Bengisu Molyer, et al.
Foilsithe / Cruthaithe: (2021-11-01)

Upregulation of lnc-ZNF281 Inhibits the Progression of Glioma via the AKT/GSK-3β/β-Catenin Signaling Pathway
de réir: Yu-Qin Deng, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Expression of ZNF281 in colorectal cancer correlates with response to radiotherapy and survival
de réir: Changjiang Qin, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Nanoparticle delivery of an AKT/PDK1 inhibitor improves the therapeutic effect in pancreatic cancer
de réir: Lucero-Acuña A, et al.
Foilsithe / Cruthaithe: (2014-12-01)

Organophosphorus S-adenosyl-L-methionine mimetics: synthesis, stability, and substrate properties
de réir: Alexander Yu Rudenko, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Angiopoietin-1 Mimetic Nanoparticles for Restoring the Function of Endothelial Cells as Potential Therapeutic for Glaucoma
de réir: Raphael Mietzner, et al.
Foilsithe / Cruthaithe: (2021-12-01)

MediJokes
Foilsithe / Cruthaithe: (2006-01-01)

Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition
de réir: Jianguo Zhuang, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Analisis Yuridis Perbandingan Risiko Medis dengan Kelalaian Medis
de réir: Abdul Kolib
Foilsithe / Cruthaithe: (2020-07-01)

Potential of Peptides as Inhibitors and Mimotopes: Selection of Carbohydrate-Mimetic Peptides from Phage Display Libraries
de réir: Teruhiko Matsubara
Foilsithe / Cruthaithe: (2012-01-01)

Caloric restriction and its mimetics in heart failure with preserved ejection fraction: mechanisms and therapeutic potential
de réir: Alexander Fuerlinger, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Nonconventional amide bond formation catalysis: programming enzyme specificity with substrate mimetics
de réir: F. Bordusa
Foilsithe / Cruthaithe: (2000-05-01)

Heparanase in cancer progression: Structure, substrate recognition and therapeutic potential
de réir: Fengyan Yuan, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Carbohydrate Mimetic Peptides for Pan Anti-Tumor Responses
de réir: Thomas eKieber-Emmons, et al.
Foilsithe / Cruthaithe: (2014-06-01)

15.281 Advanced Managerial Communication, Spring 2009
de réir: Hartman, Neal
Foilsithe / Cruthaithe: (2009)

15.281 Advanced Managerial Communication, Spring 2004
de réir: Hartman, Neal
Foilsithe / Cruthaithe: (2010)

ZAT 281/4 - PENGANTAR MIKROPEMPROSES FEB 04.
de réir: PPSF, Pusat Pengajian Sains Fizik
Foilsithe / Cruthaithe: (2004)

ZAT 281/4 - PENGANTAR MIKROPEMPROSES APR 2003.
de réir: PPSF, Pusat Pengajian Sains Fizik
Foilsithe / Cruthaithe: (2003)

ZAT 281/4 - PENGANTAR MIKROPEMPROSES FEB 03.
de réir: PPSF, Pusat Pengajian Sains Fizik
Foilsithe / Cruthaithe: (2003)

ZAT 281-3 - INTRODUCTION TO MICROPROCESSORS APRIL 08.
de réir: PPSF, Pusat Pengajian Sains Fizik
Foilsithe / Cruthaithe: (2008)